83/100BSalesforce stock forecast 2027–2031What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Salesforce is 274.18, 28.3% above the current price of 213.67. Their targets range from 215.00 to 325.00.
Of the 36 firms that rated Salesforce in the past 12 months, 25 rate it buy or strong buy, 10 hold and 1 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 215.00 to 325.00, with an average of 274.18.
| Buy | 25 | |
| Hold | 10 | |
| Sell | 1 |
12-month price target
| Highest target | 325.00 |
| Average target | 274.18 |
| Lowest target | 215.00 |
| Current price | 213.67 |
Salesforce price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Salesforce price target and rating?
How analysts rate Salesforce, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
25 of 36 firms rate it buy now, against 26 of 37 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Salesforce analyst upgrades, downgrades and price targets
The latest rating change came on 12 October 2026, when B of A Securities upgraded Salesforce from Underperform to Buy. The most recent new target came from D.A. Davidson on 21 October 2026: 250.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 21 Oct 2026 | D.A. Davidson Gil Luria | — | 225.00 → 250.00 | +11.1% | 242.35 |
| 12 Oct 2026 | B of A Securities | Upgraded · Underperform → Buy | — | — | — |
| 17 Sept 2026 | D.A. Davidson Gil Luria | — | 200.00 → 225.00 | +12.5% | 250.54 |
| 11 Sept 2026 | Stifel Nicolaus Parker Lane | — | 275.00 | — | 248.02 |
| 11 Sept 2026 | UBS Karl Keirstead | — | 260.00 → 240.00 | -7.7% | 248.11 |
| 2 Sept 2026 | Morgan Stanley | — | 315.00 | — | 258.11 |
| 27 Aug 2026 | Monness Brian White | — | 222.00 → 266.00 | +19.8% | 249.50 |
| 27 Aug 2026 | Oppenheimer Brian Schwartz | Reiterated · Outperform | 250.00 → 275.00 | +10.0% | 205.62 |
| 27 Aug 2026 | D.A. Davidson Gil Luria | — | 200.00 | — | 205.62 |
| 25 Aug 2026 | Deutsche Bank | — | 315.00 | — | 209.06 |
| 13 Aug 2026 | Monness Brian White | — | 222.00 | — | 193.76 |
| 21 Jul 2026 | Morgan Stanley | Downgraded · Overweight → Equal Weight | — | — | — |
| 9 Jul 2026 | Keybanc | Downgraded · Overweight → Sector Weight | — | — | — |
| 1 Jul 2026 | Guggenheim | Upgraded · Neutral → Buy | — | — | — |
| 28 May 2026 | Cantor Fitzgerald Matthew VanVliet | Reiterated · Overweight | 250.00 | — | 179.52 |
| 28 May 2026 | Piper Sandler Billy Fitzsimmons | Reiterated · Overweight | 215.00 | — | 179.70 |
| 28 May 2026 | Roth Capital Richard Baldry | — | 395.00 → 325.00 | -17.7% | 177.51 |
| 28 May 2026 | KeyBanc Jackson Ader | Reiterated · Overweight | 290.00 | — | 178.81 |
| 26 Feb 2026 | Truist Financial Terry Tillman | — | 280.00 | — | 199.84 |
| 26 Feb 2026 | Oppenheimer Brian Schwartz | Reiterated · Outperform | 300.00 → 250.00 | -16.7% | 191.75 |
| 26 Feb 2026 | Goldman Sachs Gabriela Borges | — | 281.00 | — | 191.75 |
| 20 Feb 2026 | BMO Capital Keith Bachman | — | 350.00 → 235.00 | -32.9% | 187.34 |
| 10 Dec 2025 | Mizuho Securities Gregg Moskowitz | — | 340.00 | — | 261.02 |
| 4 Dec 2025 | UBS Karl Keirstead | — | 404.00 → 260.00 | -35.6% | 247.92 |
| 4 Dec 2025 | RBC Capital Rishi Jaluria | — | 250.00 | — | 247.87 |
| 4 Dec 2025 | Needham Scott Berg | Reiterated · Buy | 400.00 | — | 238.72 |
| 1 Dec 2025 | Oppenheimer Brian Schwartz | Reiterated · Outperform | 300.00 | — | 230.66 |
Salesforce EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Salesforce's EPS to grow 33.4% a year until 2029. Over the last 5 years it grew 12.2% a year, and over the last 3 years 233.7%.
Analysts expect Salesforce's revenue to grow 10.3% a year until 2029. Over the last 5 years it grew 14.3% a year, and over the last 3 years 9.8%.
Revenue
EPS
Does Salesforce beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 14.3% off the result, either way, and their revenue estimate 0.5%, over the last 12 quarters.
- EPS beats
- 64 / 85
- Revenue beats
- 68 / 85
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +14.1%
- Since
- May 2005
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q2 FY2027 | 26 Aug 2026 | 3.27 | 5.90 | +80.4% | 11.33B | 11.35B | +0.1% |
| Q1 FY2027 | 27 May 2026 | 3.13 | 3.88 | +24.0% | 11.05B | 11.13B | +0.7% |
| Q4 FY2026 | 25 Feb 2026 | 3.05 | 3.81 | +24.9% | 11.19B | 11.20B | +0.1% |
| Q3 FY2026 | 3 Dec 2025 | 2.86 | 3.25 | +13.6% | 10.27B | 10.26B | -0.1% |
| Q2 FY2026 | 3 Sept 2025 | 2.78 | 2.91 | +4.7% | 10.14B | 10.24B | +0.9% |
| Q1 FY2026 | 28 May 2025 | 2.55 | 2.58 | +1.2% | 9.76B | 9.83B | +0.7% |
| Q4 FY2025 | 26 Feb 2025 | 2.61 | 2.78 | +6.5% | 10.04B | 9.99B | -0.5% |
| Q3 FY2025 | 3 Dec 2024 | 2.44 | 2.41 | -1.2% | 9.37B | 9.44B | +0.8% |
| Q2 FY2025 | 28 Aug 2024 | 2.36 | 2.56 | +8.5% | 9.22B | 9.33B | +1.1% |
| Q1 FY2025 | 29 May 2024 | 2.38 | 2.44 | +2.5% | 9.15B | 9.13B | -0.2% |
| Q4 FY2024 | 28 Feb 2024 | 2.26 | 2.29 | +1.3% | 9.22B | 9.29B | +0.7% |
| Q3 FY2024 | 29 Nov 2023 | 2.06 | 2.11 | +2.4% | 8.71B | 8.72B | +0.1% |
Salesforce stock price 2027–2031: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Salesforce's earnings keep growing at the 13.8% a year analysts expect to FY2029, it would earn about 23.97 a share in FY2031. At the P/E it has traded at over the last five years (19.4 to 53.1) that is 465.63 to 1,271.89 a share, or 795.26 at its average P/E of 33.2. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 16.75 | 325.43 | 555.81 | 888.93 |
| FY2028 | 16.07 | 312.08 | 533.02 | 852.47 |
| FY2029 | 18.50 | 359.44 | 613.89 | 981.82 |
| FY2030 (extrapolated) | 21.06 | 409.10 | 698.72 | 1,117.48 |
| FY2031 (extrapolated) | 23.97 | 465.63 | 795.26 | 1,271.89 |
Each year's EPS is the analysts' consensus to FY2029; the years after grow 13.8% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (19.4, 33.2, 53.1).
Is Salesforce stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Salesforce's P/E of 19.4 is near the bottom of its 5-year range (17.3 to 1,083.3, median 64.7). Analysts expect slower growth than in recent years, so the low P/E may be deserved. Buyers pay less for each point of growth than usual: a PEG of 0.6 on expected growth against 5.3 on its median P/E and past five years' growth. Growing 33.4% a year, Salesforce earns a P/E of 25.0 at a PEG of 1 (at most 25): × the next twelve months' EPS of 16.22, a fair value of 405.57; the price, 213.67, is 47.3% below it. Its forward P/E, on the consensus for FY2027, is 12.8.
Fair value on growth is a P/E equal to the EPS growth analysts expect a year (a PEG of 1, at most 25) times the earnings per share of the next twelve months; the ends of the bar are a PEG of 0.75 and 1.25 (a P/E of 18.8 and 31.3). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 19.42
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 64.74
- Five-year P/E range
- 17.3 – 1,083.3
- Forward P/E (FY2027)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 12.75
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 1.41
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +28.3%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 194.93146Price 99.09244 | +96.7% | |
| 42.225 | 82.9546Price 42.23165 | +96.4% | |
| 186.680 | 360.82271Price 186.68451 | +93.3% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 160.650 | 300.09225Price 160.65375 | +86.8% | |
| 165.860 | 308.95212Price 165.86442 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.